Answers are grounded in this paper and cite their sources.
Interdisciplinary center accelerates research on neurodegenerative diseases in a hybrid computing environment, suggesting innovative solutions.
The Center for Learning, Artificial Intelligence, and Advanced Research (CLARA) represents a pioneering interdisciplinary Center of Excellence — the first of its kind in Central and Eastern Europe — established to advance the development of next-generation artificial intelligence, machine learning, and quantum-enabled supercomputing technologies. Its primary objective is to accelerate research on neurodegenerative disorders, with a particular focus on Alzheimer’s disease, through the integration and analysis of large-scale biological and clinical datasets using state-of-the-art computational methodologies. The CLARA Testbed is an advanced distributed High-Performance and Quantum Computing (HPCQC) platform designed to advance research in brain science and neurodegenerative disease. By integrating high-performance computing, quantum computing, and artificial intelligence, it offers a hybrid environment capable of addressing computational challenges that surpass the reach of traditional supercomputing methods.
No takes yet. Share an insight, caveat, or question.
Vondrák et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: